{‘She has little qualifications’: this American healthcare establishment prepares for Høeg's tenure at the FDA.

Given that the US proceeds with sweeping revisions to its immunization recommendations, one figure has surfaced somewhat surprisingly: Dr. Tracy Beth Høeg, a US-based sports physician and public health researcher who first made her name by expressing skepticism about Covid vaccines during the global health crisis and has zeroed in on possible fatalities after Covid vaccination in her brief tenure at the Food and Drug Administration.

Scheduled Changes to Pediatric Vaccine Program

Public health authorities planned to reveal radical changes to the pediatric vaccine schedule in December, synchronizing the US with the Danish national calendar, sources say – a substantial departure that would put the US out of step with much of the world with little proof for improved outcomes. The announcement has been pushed back until the coming year.

Instead of the top vaccines chief, Høeg is scheduled to present at the meeting. She was recently named temporary leader of the FDA’s CDER, the fifth individual to head the division this calendar year.

A New Direction at the FDA

Høeg's temporary position might represent a tighter collaboration between the pharmaceutical and biologics centers as Dr. Høeg and Prasad consolidate power at the agency – and it signals a renewed priority upon rolling back already-approved vaccines at the FDA.

The new acting director has repeatedly called for ending specific childhood shot schedules in the US so as to align more like Denmark's approach, a nation with comprehensive healthcare and a citizenry approximately the size of the state of Wisconsin.

To date comments, she has continued to focus on vaccination policy – traditionally the responsibility of Prasad, chief of the FDA’s vaccine center – instead of medication approval.

Questions Over Qualifications

The appointee has little discernible background in medication creation, approval processes or administrative roles, which has been standard for previous heads of the Center for Biologics Evaluation and Research. She has served at the FDA as a senior adviser to the FDA chief and the vaccine center since spring.

“It seems she lacks to have the necessary background” for running the pharmaceutical oversight division, remarked a neurologist and psychiatrist. “She has not conducted a clinical trial. She lacks experience in managing a large organization. She is not an expert in industry regulation.”

Past heads of CBER would “be deeply familiar with laws and regulations and the research of pharmaceutical innovation”, noted Dr. Janet Woodcock. “Objectively, she doesn’t have the kind of background that previous people who headed the center have had.”

CDER has an vast range of responsibilities at the agency, Woodcock pointed out.

“The public just zeroes in on the new drug program, but the off-patent medication office clears a multitude of generic drugs. There is also a biologic copycat branch, OTC medication office and so forth, and each of these have to be managed,” she noted. “The area you overlook, that is precisely what that I always told people is going to cause problems.”

Furthermore, a significant management component to the role, which supervises in excess of 5,000 personnel. “It is a enormous administrative position, if you execute it properly,” the former official said.

Official Statement and Controversial Policies

In response to inquiries about Dr. Høeg's credentials and whether this selection represents increased cooperation among FDA leaders on vaccines, a representative stated that the “inquiries rely on inaccurate assumptions”.

“Her experience aligns with the duties of her role,” the representative stated, pointing to the months Dr. Høeg spent counseling the FDA commissioner on “drug safety and regulatory science, including computational safety modeling and shot safety tracking”.

As the temporary head, Høeg assumes responsibility for the commissioner’s new priority voucher program, a disputed rapid therapy clearance system that apparently concerned her predecessors. “How are these medications being chosen for this voucher program? Who takes the calls?” Dr. Howard questioned. “There is a lot of confidentiality happening at the regulatory body right now.”

Broadly speaking, he said, “the agency seems to be moving towards less stringent oversight of pharmaceuticals, except for shots.”

Established Past Work on Vaccines

With immunizations, Dr. Høeg has a clearer, if concerning, history, Howard said. She authored a analysis using unconfirmed crowd-sourced reports to assess the frequency of heart inflammation following Covid vaccination. She advised the state of Florida top health official Joseph Ladapo, who reportedly have changed statistics to indicate Covid vaccines are riskier than they are.

Part of her “wish list” for the new government included revising rules for new vaccines and ending “non-essential” vaccines, she stated post-election on a online show. At the agency, Dr. Høeg has according to sources floated the idea of excluding teenage boys from receiving Covid vaccines.

“She’s an complete ideologue who starts off with her beliefs and works backwards to retrofit the evidence in a highly deceptive, untruthful fashion,” Dr. Howard said.

Taking Control and a “Revenge Tour”

Høeg joined other dissenters, {like|